Pulling the latest in this topic…
C-suite moves, stocks, investments, M&A
2142 briefings briefings in Business
EU competition regulators have a hard deadline and two separate tracks: standard antitrust review plus foreign-subsidy scrutiny.
His trust line explains his break with Sam Altman, and how Anthropic thinks AI safety coordination should work.
If your FortiGate handles VPN or admin access, rotate passwords and verify MFA, because stolen logins can mean total network takeover.
Why the US Commerce Department is funding physics-and-chemistry AI to replace foreign minerals, including PFAS-free processes.
The company moves forward on an FDA path for its Huntington’s gene therapy, months after a public data dispute.
The $22 billion tie-up adds scale and leverage, forcing rivals, boards, and platforms to rethink how streaming dollars flow.
For boards betting on AI power demand, “announced capacity” may be a mirage: delays, grid issues, and duplicative counting.
Sphere Entertainment plans advanced-tech upgrades so the 1976 cult classic looks right on a curved screen.
CNBC says SpaceX’s shares surge following its IPO Friday, forcing investors to reprice what “space” and “AI” are worth.
Big IPO, bigger options debut: what it means for investors, risk teams, and anyone benchmarking market appetite.
SpaceX exercised its option for Cursor in an all-stock deal worth $60 billion, reshaping AI dealmaking expectations.
The valuation jump of $1T in a single day changes the reference point for risk capital and public-market comps.
